高级检索
当前位置: 首页 > 详情页

Impact on Short-Term Complications of Early Oral Feeding in Patients with Esophageal Cancer After Esophagectomy

| 导出 | |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Intensive Care Unit, Sichuan Cancer Hospital & Institute, Chengdu, Sichuan, China [2]Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute, Chengdu, Sichuan, China [3]Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center. School of Medicine, University of Electronic Science and Technology of China, Chengdu, China [4]Translational Centre for Oncoimmunology, Sichuan Cancer Hospital & Institute, Chengdu, Sichuan, China
出处:
ISSN:

摘要:
To evaluate early oral feeding (EOF) in short-term outcomes of patients with esophageal cancer after esophagectomy. 179 patients with esophageal cancer who underwent esophagectomy between January 2016 and February 2018 were enrolled for this study. 87 patients with EOF without nasogastric tube or nasogastric tube was removed within 24 h, were selected as the experimental group, whereas 92 patients who received nasojejunal tube feeding were set as the control group. All laboratory testing, clinical features, and hospitalization expenses were compared between the two groups. No statistical significance was observed between the two groups in hemoglobin, albumin, and prealbumin levels after esophagectomy. Notably, there was no significant difference in the incidence of severe pneumonia and anastomotic leakage between the two groups. Admittance period, postoperative defecation time, and medical expenses were significantly decreased among patients with EOF (P < 0.001). Multivariate Cox multiple-factor regression analysis revealed that there was no correlation between EOF and the risk of anastomotic leakage. EOF might not be a risk factor for increasing the incidence of severe pneumonia and anastomotic leakage in patients with esophageal cancer after esophagectomy, and it could reduce the hospitalization period as well as control medical expenses.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 营养学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 营养学 4 区 肿瘤学
JCR分区:
出版当年[2021]版:
Q3 NUTRITION & DIETETICS Q4 ONCOLOGY
最新[2023]版:
Q3 NUTRITION & DIETETICS Q3 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Department of Intensive Care Unit, Sichuan Cancer Hospital & Institute, Chengdu, Sichuan, China
通讯作者:
通讯机构: [1]Department of Intensive Care Unit, Sichuan Cancer Hospital & Institute, Chengdu, Sichuan, China [3]Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center. School of Medicine, University of Electronic Science and Technology of China, Chengdu, China [4]Translational Centre for Oncoimmunology, Sichuan Cancer Hospital & Institute, Chengdu, Sichuan, China [*1]Sichuan Cancer Center, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Suite 246, 3rd Inpatient Building, 55 4th section of South Renmin Road, Chengdu, Sichuan, China [*2]Department of Intensive Care Unit, Sichuan Cancer Hospital & Institute, Chengdu, Sichuan, 610041, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43370 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号